BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26756419)

  • 1. Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma.
    Singh SR; Sullo N; Matteis M; Spaziano G; McDonald J; Saunders R; Woodman L; Urbanek K; De Angelis A; De Palma R; Berair R; Pancholi M; Mistry V; Rossi F; Guerrini R; Calò G; D'Agostino B; Brightling CE; Lambert DG
    Br J Pharmacol; 2016 Apr; 173(8):1286-301. PubMed ID: 26756419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptin reduces the inflammatory immune microenvironment in a conventional murine model of airway hyperresponsiveness.
    Spaziano G; Sorrentino R; Matteis M; Malgieri G; Sgambato M; Russo TP; Terlizzi M; Roviezzo F; Rossi F; Pinto A; Fattorusso R; D'Agostino B
    Clin Exp Allergy; 2017 Feb; 47(2):208-216. PubMed ID: 27562660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptin/orphanin FQ receptor activation decreases the airway hyperresponsiveness induced by allergen in sensitized mice.
    Sullo N; Roviezzo F; Matteis M; Ianaro A; Calò G; Guerrini R; De Gruttola L; Spaziano G; Cirino G; Rossi F; D'Agostino B
    Am J Physiol Lung Cell Mol Physiol; 2013 May; 304(10):L657-64. PubMed ID: 23502511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nociceptin/Orphanin Fq in inflammation and remodeling of the small airways in experimental model of airway hyperresponsiveness.
    Tartaglione G; Spaziano G; Sgambato M; Russo TP; Liparulo A; Esposito R; Mirra S; Filosa R; Roviezzo F; Polverino F; D'Agostino B
    Physiol Rep; 2018 Oct; 6(20):e13906. PubMed ID: 30370666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of nociceptin peptide (N/OFQ)-receptor (NOP) system activation in the airways.
    Singh SR; Sullo N; D'Agostino B; Brightling CE; Lambert DG
    Peptides; 2013 Jan; 39():36-46. PubMed ID: 23123316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nociceptin modulates bronchoconstriction induced by sensory nerve activation in mouse lung.
    D'Agostino B; Orlotti D; Calò G; Sullo N; Russo M; Guerrini R; De Nardo M; Mazzeo F; Candeletti S; Rossi F
    Am J Respir Cell Mol Biol; 2010 Feb; 42(2):250-4. PubMed ID: 19448152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro sepsis up-regulates Nociceptin/Orphanin FQ receptor expression and function on human T- but not B-cells.
    Bird MF; Hebbes CP; Tamang A; Willets JM; Thompson JP; Guerrini R; Calo G; Lambert DG
    Br J Pharmacol; 2023 Sep; 180(17):2298-2314. PubMed ID: 37021779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y; Simpson-Durand CD; Standifer KM
    Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nociceptin/orphanin FQ-NOP receptor system in inflammatory and immune-mediated diseases.
    Gavioli EC; de Medeiros IU; Monteiro MC; Calo G; Romão PR
    Vitam Horm; 2015; 97():241-66. PubMed ID: 25677775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux.
    D'Agostino B; Marrocco G; De Nardo M; Calò G; Guerrini R; Gallelli L; Advenier C; Rossi F
    Br J Pharmacol; 2005 Mar; 144(6):813-20. PubMed ID: 15685213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
    Gavioli EC; Calo' G
    Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N/OFQ-NOP System and Airways.
    D'Agostino B; Sgambato M; Esposito R; Spaziano G
    Handb Exp Pharmacol; 2019; 254():313-322. PubMed ID: 30725285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific estrogen and progestin regulation of orphanin FQ/nociceptin and nociceptin opioid receptor mRNA expression in the female rat limbic hypothalamic system.
    Sinchak K; Romeo HE; Micevych PE
    J Comp Neurol; 2006 May; 496(2):252-68. PubMed ID: 16538678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys.
    Rizzi A; Sukhtankar DD; Ding H; Hayashida K; Ruzza C; Guerrini R; Calò G; Ko MC
    Br J Pharmacol; 2015 Jul; 172(14):3661-70. PubMed ID: 25828800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
    Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
    Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences.
    Rizzi A; Nazzaro C; Marzola GG; Zucchini S; Trapella C; Guerrini R; Zeilhofer HU; Regoli D; Calo' G
    Pain; 2006 Sep; 124(1-2):100-8. PubMed ID: 16697109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system.
    Thomas RC; Bath MF; Stover CM; Lambert DG; Thompson JP
    Peptides; 2014 Nov; 61():56-60. PubMed ID: 25161013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.
    Donica CL; Awwad HO; Thakker DR; Standifer KM
    Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.